Barclays PLC Grows Holdings in Core Laboratories Inc. (NYSE:CLB)

Barclays PLC increased its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 288.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,570 shares of the oil and gas company's stock after acquiring an additional 62,042 shares during the period. Barclays PLC owned about 0.18% of Core Laboratories worth $1,549,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. The Manufacturers Life Insurance Company boosted its holdings in Core Laboratories by 3.3% in the second quarter. The Manufacturers Life Insurance Company now owns 18,054 shares of the oil and gas company's stock valued at $366,000 after purchasing an additional 579 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in Core Laboratories by 11.9% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company's stock valued at $114,000 after purchasing an additional 600 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of Core Laboratories by 1.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 54,310 shares of the oil and gas company's stock valued at $1,102,000 after buying an additional 758 shares during the period. GAMMA Investing LLC grew its position in shares of Core Laboratories by 33.0% during the third quarter. GAMMA Investing LLC now owns 5,885 shares of the oil and gas company's stock worth $109,000 after buying an additional 1,460 shares in the last quarter. Finally, Isthmus Partners LLC increased its stake in shares of Core Laboratories by 18.8% during the third quarter. Isthmus Partners LLC now owns 10,620 shares of the oil and gas company's stock worth $197,000 after buying an additional 1,682 shares during the period. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have commented on CLB. StockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Citigroup decreased their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a research report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $17.00.

Core Laboratories Stock Performance

Shares of Core Laboratories stock opened at $18.09 on Monday. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. Core Laboratories Inc. has a 52 week low of $13.82 and a 52 week high of $25.13. The firm's 50 day moving average is $19.27 and its two-hundred day moving average is $19.60. The firm has a market capitalization of $849.33 million, a P/E ratio of 27.83, a P/E/G ratio of 1.36 and a beta of 2.39.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The firm had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. During the same period last year, the business earned $0.22 EPS. Core Laboratories's revenue for the quarter was up 7.2% compared to the same quarter last year. Research analysts forecast that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were given a $0.01 dividend. The ex-dividend date was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.22%. Core Laboratories's dividend payout ratio (DPR) is presently 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.